Please assess the completion status of the following clinical trial:

Trial Title: ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Bilateral limbal stem cell deficiency of any etiology.~2. Corneal impression cytology positive for goblet cells.~3. Ocular ultrasound results within normal parameters.~4. Agree to participate in the study and sign the informed consent.~Exclusion Criteria:~1. Active immunological diseases.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Stem Cell Transplantation (Type: EXPERIMENTAL): Cultivated Limbal Stem Cell Transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).